Use of patient-reported outcome measures and inflammatory biomarkers to differentiate chronic rhinosinusitis with nasal polyp endotypes: Is it feasible?

Ann Allergy Asthma Immunol. 2023 Apr;130(4):409-410. doi: 10.1016/j.anai.2023.01.004.NO ABSTRACTPMID:37005049 | DOI:10.1016/j.anai.2023.01.004

Source: Annals of Allergy, Asthma and Immunology - April 2, 2023 Category: Allergy & Immunology Authors: Jonathan A Bernstein Source Type: research